Everett Harris & Co. CA Has $1.89 Million Holdings in CVS Health Co. (NYSE:CVS)

Everett Harris & Co. CA reduced its stake in CVS Health Co. (NYSE:CVS) by 6.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,695 shares of the pharmacy operator’s stock after selling 1,506 shares during the quarter. Everett Harris & Co. CA’s holdings in CVS Health were worth $1,890,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in CVS. Atticus Wealth Management LLC raised its position in CVS Health by 149.0% in the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 219 shares during the last quarter. USA Financial Formulas lifted its position in CVS Health by 573.2% during the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. acquired a new position in shares of CVS Health during the 4th quarter worth about $32,000. Creekmur Asset Management LLC acquired a new stake in shares of CVS Health in the fourth quarter valued at about $34,000. Finally, Steph & Co. increased its position in shares of CVS Health by 192.0% in the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 288 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Insider Activity at CVS Health

In related news, Director Edward J. Ludwig purchased 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was acquired at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the acquisition, the director now owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.24% of the stock is owned by insiders.

CVS Health Stock Down 1.4 %

Shares of CVS stock traded down $0.82 on Thursday, reaching $56.70. 5,371,350 shares of the company were exchanged, compared to its average volume of 10,197,653. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The company has a market cap of $71.18 billion, a price-to-earnings ratio of 9.96, a PEG ratio of 0.55 and a beta of 0.52. The company has a 50-day moving average of $58.89 and a 200-day moving average of $69.81. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The firm had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. During the same quarter in the prior year, the firm earned $2.20 EPS. The company’s revenue was up 3.7% compared to the same quarter last year. Analysts anticipate that CVS Health Co. will post 7.02 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CVS. Piper Sandler boosted their price objective on shares of CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, March 15th. SVB Leerink restated a “market perform” rating and issued a $60.00 price target (down previously from $87.00) on shares of CVS Health in a research note on Wednesday, May 1st. Robert W. Baird began coverage on shares of CVS Health in a research report on Thursday, May 30th. They set a “neutral” rating and a $61.00 price objective for the company. Bank of America cut their target price on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $58.00 price target on shares of CVS Health in a report on Wednesday, June 12th. Eleven research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $75.05.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.